Resources
Advanced Search
Start Free Trial
Talk With Sales
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Biosergen
Growth Score
71
CB Rank
73861
Heat Score
68
Save
Actions
Biosergen develops variants of nystatin with improved properties.
Founded
obfuscated
obfuscation
Public
Post-IPO Equity
Trondheim
,
Sor-Trondelag
,
Norway
1-10
www.biosergen.net
Biotechnology
Pharmaceutical
Biosergen
Section: Technology
Actions